Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer

NCT04111510 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Triple Negative Breast Cancer

Interventions

DRUG: Tumor infiltrating lymphocytes (TIL) LN-145

Sponsor

Yale University

Collaborators

[object Object]